Application

19539493 · Compounds with Anti-KRAS Mutated Tumor Activity

Filed 2026-02-13 · Pending The official file ↗ · Art unit 1691 · Examiner Christopher Lindsay Johnson Typical · CPC A61K 31/4995 · Trasveda Ltd. · BANNER & WITCOFF, LTD.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

1.6 mo

to disposition n/a

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.